SCHEMBL16475554

SCHEMBL16475554

CC1(CO)COC(c2ccco2)=N1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 2/20 0.39
LPL P06858 1/20 0.35
LIPG Q9Y5X9 1/20 0.35
ALDH1A1 P00352 6/20 0.34
KDM4E B2RXH2 5/20 0.34
POLB P06746 4/20 0.34
HPGD P15428 4/20 0.34
MAPT P10636 3/20 0.34
L3MBTL1 Q9Y468 3/20 0.34
NPC1 O15118 2/20 0.34
RAB9A P51151 2/20 0.34
MEN1 O00255 2/20 0.34
PKM P14618 2/20 0.34
ALOX15 P16050 2/20 0.34
CASP1 P29466 2/20 0.34
PTPN7 P35236 2/20 0.34
RECQL P46063 2/20 0.34
BLM P54132 2/20 0.34
CASP7 P55210 2/20 0.34
KMT2A Q03164 2/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL764323 0.79 KDM4E (0.54) LMNALPLLIPGALDH1A1KDM4E
SCHEMBL12471989 0.76 LMNA (0.66) LMNAALDH1A1KDM4EMAPT
SCHEMBL16459165 0.74 LMNA (0.62) LMNALPLLIPGKDM4EMAPT
SCHEMBL16475556 0.73 LMNA (0.42) LMNALPLLIPGALDH1A1KDM4E
SCHEMBL16459758 0.72 LMNA (0.47) LMNAALDH1A1KDM4EMAPTKMT2A
SCHEMBL16459876 0.72 LMNA (0.38) LMNAALDH1A1KDM4E
SCHEMBL16458474 0.72 LMNA (0.41) LMNAALDH1A1KDM4E
SCHEMBL16459658 0.72 HPGD (0.39) LMNALPLLIPGALDH1A1KDM4E
SCHEMBL23480876 0.71 LMNA (0.46) LMNAALDH1A1KDM4EMAPTNPC1
SCHEMBL16459397 0.71 LMNA (0.46) LMNAALDH1A1KDM4EPOLBMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8969585-B2 Method for producing optically active compound or salt thereof NAGASAKI UNIVERSITY (JP) 2015-03-03 US disclosed
US-8969585-B2 Method for producing optically active compound or salt thereof NAGASAKI UNIVERSITY (JP) 2015-03-03 US disclosed
US-20140012010-A1 METHOD FOR PRODUCING OPTICALLY ACTIVE COMPOUND OR SALT THEREOF NAGASAKI UNIVERSITY (JP) 2014-01-09 US disclosed
US-20140012010-A1 METHOD FOR PRODUCING OPTICALLY ACTIVE COMPOUND OR SALT THEREOF NAGASAKI UNIVERSITY (JP) 2014-01-09 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140012010-A1 METHOD FOR PRODUCING OPTICALLY ACTIVE COMPOUND OR SALT THEREOF MINK1, MELK, MRPL21 LMNA 1949/4885LPL 1112/4885LIPG 2935/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.